Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
363-01-002 ISMRM Abstract

Paired Regional Complementarity in Diffusion MRI Reveals Disease-Specific Microstructural Profiles in PD, MSA, and PSP

Primary: Diffusion - Diffusion Analysis & Visualization
Secondary: Analysis Methods - Classification and Prediction
363-01-002 · Neurological Application of Advanced Diffusion and Quantitative MRI · Monday, 11 May, 8:20 AM–9:15 AM · Digital Posters Row D
Keywords: Tractography Diffusion Tensor Imaging Parkinsonian Syndromes Differential diagnosis.
Accepted
Abel W Tessema 1,2, HyungJoon Cho1
1Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Korea, Republic of
2School of Biomedical Engineering, Jimma University, Jimma Institute of Technology, Jimma, Ethiopia
Presenting Author: Abel W Tessema

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. J. Jankovic, “Parkinson’s disease: Clinical features and diagnosis,” J. Neurol. Neurosurg. Psychiatry, vol. 79, no. 4, pp. 368–376, 2008.
2. N. R. McFarland, “Diagnostic Approach to Atypical Parkinsonian Syndromes,” Continuum (Lifelong Learn Neurol), vol. 22, no. 4, pp. 1117–1138, 2016.
3. D. E. Vaillancourt et al., “Automated Imaging Differentiation for Parkinsonism,” JAMA Neurol., vol. 82, no. 5, pp. 495–505, 2025.
4. A. Worker et al., “Diffusion tensor imaging of Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy,” PLoS One, vol. 9, no. 11, 2014.
5. D. Paviour et al., “Regional brain volumes distinguish PSP, MSA-P, and PD,” Mov. Disord., vol. 21, no. 7, pp. 989–996, 2006.
6. M. Liu, Z. Wang, and H. Shang, “Multiple system atrophy: an update and emerging directions,” J. Neurol., vol. 271, no. 5, pp. 2324–2344, 2024.
7. J. H. Lee and M. S. Lee, “Brain iron accumulation in atypical parkinsonian syndromes,” Front. Neurol., vol. 10, p. 74, 2019.
8. V. Beliveau et al., “Characterization and diagnostic potential of diffusion tractography in multiple system atrophy,” Parkinsonism Relat. Disord., vol. 85, pp. 30–36, 2021.
9. P. J. Basser and D. K. Jones, “Diffusion-tensor MRI: Theory, experimental design and data analysis,” NMR Biomed., vol. 15, pp. 456–467, 2002.
10. P. Mukherjee et al., “Diffusion tensor MR imaging and fiber tractography: Theoretic underpinnings,” AJNR Am. J. Neuroradiol., vol. 29, no. 4, pp. 632–641, 2008.
11. H. G. Yang et al., “Cerebellar atrophy and its contribution to motor and cognitive performance in MSA,” NeuroImage Clin., vol. 23, p. 101891, 2019.
12. J. Saini et al., “In vivo evaluation of white matter pathology in PSP using TBSS,” Neuroradiology, vol. 54, no. 7, pp. 771–780, 2012.
13. Y. Zhang et al., “Diffusion tensor imaging of the nigrostriatal fibers in PD,” Mov. Disord., vol. 30, no. 9, pp. 1229–1236, 2015.
14. F. Costa et al., “Longitudinal assessment of white matter alterations in PSP variants using diffusion tractography,” Parkinsonism Relat. Disord., vol. 132, 2025.
15. J. Pasquini et al., “Diffusion MRI microstructural abnormalities in MSA: A comprehensive review,” Mov. Disord., vol. 37, no. 10, pp. 1963–1984, 2022.
16. H. J. Huppertz et al., “Differentiation of neurodegenerative parkinsonian syndromes by volumetric MRI and SVM classification,” Mov. Disord., vol. 31, no. 10, pp. 1506–1517, 2016.
17. M. Miki et al., “Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy,” Brain, vol. 144, no. 4, pp. 1138–1151, 2021.
18. T. Potrusil et al., “Diagnostic potential of automated tractography in PSP variants,” Parkinsonism Relat. Disord., vol. 72, pp. 65–71, 2020.
19. Y. Zhang et al., “Diffusion tensor imaging of the nigrostriatal fibers in Parkinson’s disease,” Mov. Disord., vol. 30, no. 9, pp. 1229–1236, 2015.
20. S. Ito et al., “Diffusion tensor analysis of corpus callosum in PSP,” Neuroradiology, vol. 50, no. 11, pp. 981–985, 2008.
21. M. E. Caligiuri et al., “Corpus callosum damage in PSP and unsteady PD patients: A multimodal MRI study,” Neuroimage (Amst)., vol. 43, p. 103642, 2024.
22. J. Rosskopf et al., “Frontal corpus callosum alterations in PSP but not PD,” Neurodegener. Dis., vol. 14, no. 4, pp. 184–193, 2014.
23. N. Ramli et al., “Differentiating MSA from Parkinson’s disease,” Clin. Radiol., vol. 70, no. 5, pp. 555–564, 2015.
24. L. A. Massey et al., “Conventional MRI in confirmed PSP and MSA,” Mov. Disord., vol. 27, no. 14, pp. 1754–1762, 2012.
25. A. Abos et al., “Differentiation of MSA from PD by structural connectivity,” Sci. Rep., vol. 9, 2019.
26. C. Xu et al., “A Predictive Visual Analytics System for Studying Neurodegenerative Disease Based on DTI Fiber Tracts,” IEEE Trans. Vis. Comput. Graph., vol. 29, no. 4, pp. 2020–2035, 2023.
27. Y. C. Shih et al., “Recent advances in using DTI to study white matter alterations in PD,” Front. Aging Neurosci., vol. 14, 2022.
28. J. Pasquini et al., “Diffusion MRI microstructural abnormalities in MSA: A comprehensive review,” Mov. Disord., vol. 37, 2022.
29. O. A. Forsman et al., “Combined MR quantitative susceptibility mapping and multi-shell diffusion in Parkinson’s disease,” J. Neuroimaging, vol. 34, no. 5, pp. 603–611, 2024.
30. Tessema AW, Lee H, Gong Y, et al. Automated volumetric determination of high R2* regions in substantia nigra: A feasibility study of quantifying substantia nigra atrophy in progressive supranuclear palsy. NMR Biomed. 2022;35(11):e4795. doi:10.1002/NBM.4795 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/363-01-002